All components are absorbed within 60-90 days1,2,4,5
1. Bioabsorbable Anchor: Begins to hydrate and soften 24-36 hours after deployment6 and is absorbed 95% at 42 days6
2. Bioabsorbable Collagen: Designed to conform to the arteriotomy for confident closure2
3. Bioabsorbable Suture: Tethers the anchor and collagen together, providing a secure seal2
| Part Number | French Size | Guidewire Diameter (in) |
| 610130 | 6Fr | .035 Wire |
| 610131 | 8Fr | .038 Wire |
ANGIO-SEAL MRI Safety - Is ANGIO-SEAL MRI safe?
The implanted components of the device are MRI safe. The product is not made with natural rubber latex.9
Types of Vascular Closure Devices - What are some common types of vascular closure devices?
Percutaneous Closure Devices: These devices are inserted through a small incision in the skin and are guided to the puncture site to close the artery. They may use sutures, collagen plugs, or other mechanisms for closure.
Collagen Plugs or Sealants: Collagen-based plugs or sealants promote clot formation and provide a physical barrier to reduce bleeding, often used in combination with other closure methods.
Clip-Based Devices: These devices use clips or clamps to secure the arterial puncture site.
Vascular Compression Devices: These devices apply external pressure to the puncture site, aiding in hemostasis. They are commonly used alongside other closure devices.
Indications: The Angio-Seal Vascular Closure Device is indicated for use in closing and reducing time to hemostasis of the femoral arterial puncture site in patients who have undergone diagnostic angiography procedures or interventional procedures using an 8 French or smaller procedural sheath for the 8 F Angio-Seal device and a 6 French or smaller procedural sheath for the 6 F Angio-Seal device. Angio-Seal is also indicated for use to allow patients who have undergone diagnostic angiography to safely ambulate as soon as possible after sheath removal and device placement, as well as to allow patients who have undergone an interventional procedure to safely ambulate after sheath removal and device placement.
Important Safety Information: Possible adverse events for vascular closure devices include, but are not limited to: bleeding or hematoma, AV fistula or pseudoaneurysm, infection, allergic reaction, foreign body reaction, inflammation or edema. This device should only be used by physicians with training qualifying them to perform arterial access and closure for endovascular procedures through the common femoral artery and have participated in a Terumo Medical Corporation Angio-Seal physician instruction program.
Exception (applicable to US and China only): This device should only be used by a licensed physician (or other health care professional authorized by or under the direction of such physician) possessing adequate instruction in the use of the device, e.g., participation in an Angio-Seal physician instruction program or equivalent.